The MarketReader Minute
💊 Biotech sector buzzes with IGM’s cancer antibodies, Urogen’s bladder cancer breakthrough, and Genmab’s lymphoma therapy gains | Biotech Sector Insights
In the broader market context, the Russell 2000 Index rose by 1.99%, suggesting that the performance of small-cap stocks may be influencing dynamics within the biotechnology sector.